The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Dolocopin 40mg/g Cream

Ferndale Laboratories LimitedPA22869/001/001

Main Information

Trade NameDolocopin 40mg/g Cream
Active SubstancesLidocaine
Dosage FormCream
Licence HolderFerndale Laboratories Limited
Licence NumberPA22869/001/001

Group Information

ATC CodeN01BB02 lidocaine


License statusAuthorised
Licence Issued27/11/2015
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMaximum pack size for non-prescription supply: 5 g.
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back